Is Moderna a no-brainer buy on the sell-off? I wouldn't go that far. Investors should think long and hard about the company's ...

Moderna's bird flu vaccine development, supported by a U.S. government grant, could be a game changer if the bird flu spreads ...

Moderna stock has been volatile this week as the first death in the U.S. connected to bird flu was reported. Here's what you ...

Four years from now, what might we be saying about what we just lived through? The possibilities seem endless.

Tom Yeung here with your Sunday Digest. In 1909, a young physics graduate student proposed building a magnetically levitated ...

Duke neuroscientist Kafui Dzirasa wants nothing less than to reengineer the brain’s electrical patterns to treat anxiety, ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

Share prices of Moderna (NASDAQ: MRNA) plummeted 58% in 2024, ranking among the worst performers in the S&P 500 index. The ...

Norovirus, often erroneously called the "stomach flu," sickens an estimated 21 million Americans and 685 million people ...

US health officials announced Friday they were awarding $590 million to Moderna to develop mRNA vaccines against influenza, ...

Moderna plans to advance research on the mRNA vaccine into a phase 3 trial after receiving positive results in earlier phases, which it plans to present at a scientific conference in the near future.